Antigenic Imprinting and Immune Response Dynamics: Neutralization Against Emerging SARS‐CoV‐2 Omicron Variants Following Breakthrough Infections

Documenti analoghi

• Drug Repurposing: In Vitro Evaluation of Simeprevir as a Novel Antiviral Drug Against Severe Fever With Thrombocytopenia Syndrome Virus
  di: Qian Chen, et al.
  Pubblicazione: (2025)
• The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS‐CoV‐2 Omicron Variants
  di: Shuo Liu, et al.
  Pubblicazione: (2025)
• Proteomics and Phosphoproteomics Characteristics of the Rhesus Macaque Lung Infected With Original SARS‐CoV‐2, Delta, and Omicron Variants
  di: XiaoYue Tang, et al.
  Pubblicazione: (2025)
• Involucrasins Potentially Prevents SARS‐CoV‐2 Infection via Inhibiting Caspase‐1 Signaling in Several Variants
  di: Mingming Wang, et al.
  Pubblicazione: (2026)
• Dynamics of Crossed Acquired Immunity Against SARS‐CoV‐2 Variants: From Vaccine to Hybrid Immunity in China
  di: Hao Wang, et al.
  Pubblicazione: (2025)